FOS and cancer: The JUN family and FOS family activities were up-regulated in the resistant cells (Fig. 5N and Figure S8A), which had been proven to regulate E-cadherin (CDH1), N-cadherin (CDH2), and SNAIL2 expression in cancers [55–57].